Concepedia

David B. Duggan

DB

Statistics

Publications

30

Citations

3.1K

H-Index

23

Active since

1985

Affiliations

SUNY Upstate Medical University(Current)

Syracuse University

Dana-Farber Cancer Institute

Tufts University

Duke Medical Center

David B. Duggan is an author at SUNY Upstate Medical University specializing in medicine, immunology, and oncology.

Top concepts

Publications per year

1985–2021

30

Publications

30

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 1.3K citations

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

David B. Duggan, Gina R. Petroni, Jeffrey L. Johnson et al. · Journal of Clinical Oncology · 2003 · 481 citations

Failure of Higher-Dose Paclitaxel to Improve Outcome in Patients With Metastatic Breast Cancer: Cancer and Leukemia Group B Trial 9342

Eric P. Winer, Donald A. Berry, Susan Woolf et al. · Journal of Clinical Oncology · 2004 · 270 citations · Full text

Immunochemical similarities between monoclonal antibacterial Waldenstrom's macroglobulins and monoclonal anti-DNA lupus autoantibodies.

Yaakov Naparstek, David B. Duggan, Ami Schattner et al. · The Journal of Experimental Medicine · 1985 · 134 citations · Full text

, , +20

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

Daniel F. Hayes, Hideko Yamauchi, Gloria Broadwater et al. · PubMed · 2001 · 96 citations

1–5 of 30